openPR Logo
Press release

Tuberculosis Testing Market Assessment: 2017-2021

06-26-2017 04:54 PM CET | Health & Medicine

Press release from: SA-BRC

Tuberculosis is one of the most prominent infectious disease in certain under developed and developing economies, especially Asia and Africa. High mortality and quick spread led to development of rapid diagnostic methods with potential to replace traditional diagnostic methods. Earlier microbial testing was the most common confirmatory test for tuberculosis. The test took at least three days and also had drawbacks of producing false positive results. Microbial testing also increased risk of infection to laboratory personnel due to constant exposure to pure culture at all times. Enzyme-linked immunosorbent assay (ELISA), polymerase chain reaction (PCR) and microscopic observation drug susceptibility (MODS) are major types of tuberculosis tests that can provide accurate results in short period of time.

Prevalence of tuberculosis is high in low and middle income countries. In 2015, there were an estimated 10.4 million new TB cases worldwide according to data published by the World Health Organization (WHO). Patients identified HIV positive accounted for 11% if these cases. The data also mentions that 60% of the global tuberculosis population was concentrated in only 6 countries which include India, Indonesia, China, Nigeria, Pakistan and South Africa. High mortality rate has been a major concern driving the need for accurate and rapid methods of tuberculosis diagnosis. Over 1.4 million mortalities were estimated in 2015 by the WHO due to tuberculosis. Statistics shows that although the tuberculosis mortality rate has decreased by 22% between 2000 and 2015, the disease still remained one of the top 10 causes of death globally in 2015. Another major concerns associated with tuberculosis is high rate of multi drug resistant tuberculosis cases. Considering these factors the tuberculosis testing market is forecast to grow rapidly in Asia Pacific and Africa region.

Request Free Sample@

GeneXpert test (line probe assay) is a WHO approved TB diagnostic test with over 98% sensitivity and 99% specificity. The test is being provided in India at subsidized rate to target low income groups. In March 2017, Cepheid announced the launch of WHO recommended test Xpert MTB/RIF Ultra. Government initiatives to increase awareness about tuberculosis has helped in increasing diagnosis rate. Free and subsidized diagnosis and treatment camps have also helped in curbing prevalence of tuberculosis. Currently cost of diagnosis and availability of resources has been major hurdle for controlling TB prevalence in low income countries. Hence the market for tuberculosis testing would grow in the coming future.

Key players in the tuberculosis testing market include Hardy Diagnostics, Qiagen N.V., Cepheid, Accuquik, QuanDX, DiagCor Biosciences and others.

Request Report TOC@

Spearhead Acuity Business Research & Consulting Private Limited (OPC) is a premium Life Science business intelligence and data analytics firm. SA-BRC team offers a wide range of business intelligence services to multiple stakeholders such as Medical Device Manufacturers, Service Providers (Hospitals, Payers, etc.), Suppliers, Group Purchase Organizations, Distributors and all other individuals in the entire value chain of healthcare industry. Our research and consulting capabilities extend across several sub-domains within the sphere of Life Sciences such as Biotechnology, Healthcare IT, Medical Devices, Veterinary Sciences, Wellness Products and Pharmaceuticals.

Office No. 14, Hermes Kunj
Mangaldas Road, Pune, India
Phone No: +91-02041210872

This release was published on openPR.

Permanent link to this press release:

Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Tuberculosis Testing Market Assessment: 2017-2021 here

News-ID: 596519 • Views: 382

More Releases from SA-BRC

Biochip Market Analysis by Application and Trend 2017-2021
Biochips allow simultaneous testing of higher number of analytes to achieve high throughput and low cost per test. Nanotechnology has helped in miniaturization of devices to achieve higher performance standards. Microarrays are most important part of biochips which send signals to the biochip to deliver end results. Microfluidic biochips have become modern alternative to routine laboratories. Microfluidic technology which enables controlling flow of liquids in micro and pico quantities has
Acute Myeloid Leukemia Therapeutics Market Share, Analysis and Segments 2017-202 …
Acute myeloid leukemia is a cancer of blood cells and involves proliferation of abnormal blood cell types and subsequent replacement of bone marrow with cancerous cells. Major leukemia types include myeloblastic, promyeloctic, myelomonocytic, monocytic, erythroleukemia, megakaryocytic. Treatment of leukemia mainly depends on the type of leukemia and stage. Acute myeloid leukemia therapeutics market is rich with branded as well as generic drugs classified under various classes including antineoplastic agents, corticosteroids, tyrosine
Companion Diagnostics Market Share, Trends Analysis: 2017-2021
Companion diagnostics has revolutionized cancer therapeutics and enabled physicians to select specific treatment pattern from of myriad of drugs for cancer treatment. This has improved treatment outcome manyfold and has now become and indispensable part of personalized medicine. The companion diagnostics market received great attention post success of Herceptin (trastuzumab) and Gleevec (imatinib). Rapid adoption of companion diagnostics and supportive regulatory agencies have encouraged researchers to seek molecules that target
North America and Europe Bionic Eye Market Segment Analysis And Forecast: 2017-2 …
Sudden surge in bionic eye market was experienced recently after the National Health Service (NHS) announced the sponsorship to implant bionic eyes in ten patients. The bionic eye can help regain vision in individuals with visual impairment. Although currently two bionic eye systems has received regulatory approvals, other companies in the bionic eye market are also trying to develop new technology that can help in regaining visual sense in patients. The

All 5 Releases

More Releases for Tuberculosis

Tuberculosis Drugs Market Industry Forecast till 2024
Tuberculosis is a chronic condition that is often undermined, though it can be fatal if left unchecked. Thankfully, extensive awareness campaigns and initiatives by various governments to curb the menace is bearing fruit. Tuberculosis treatment helped prevent 49 million fatalities associated with the condition between 2000 and 2015. However, there are still some prominent diagnostic and treatment slits that continue. In 2015, approximately 6.1 million newly diagnosed tuberculosis cases were
Tuberculosis Vaccine Market Opportunity Analysis, 2018-2026
Tuberculosis (TB) is a highly contagious disease caused by the bacterium known as Mycobacterium tuberculosis and is mostly spread through person to person contact. It causes multisystem infection and eventually might lead to death of the infected person. Two types of TB that are commonly observed include latent TB in which the infected person do not show symptoms and active TB in which the infected person shows clinical symptoms of
Tuberculosis Diagnosis and Treatment Market
The Global Tuberculosis diagnosis and treatment market is relied upon to develop at a CAGR of 2.3 % amid 2017-2022. An irresistible illness caused by the bacterium Mycobacterium tuberculosis (MTB) is known as Tuberculosis (TB). Tuberculosis by and large influences the lungs yet can likewise influence different parts of the body. Inert tuberculosis is the sort of TB which don't have indications. Around 10% of inert contaminations advance to dynamic
Global Tuberculosis Diagnostics Sales Market Report 2018
The Global Tuberculosis Diagnostics Sales Market Report 2018 is a professional and in-depth study on the current state of the Tuberculosis Diagnostics industry. Firstly, the report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure. The Tuberculosis Diagnostics Industry analysis is provided for the international market including development history, competitive landscape analysis, and major regions’ development status. Secondly, development policies and plans are discussed as well as manufacturing processes and cost structures. This
Tuberculosis Testing Market | Analysis & Trends 2020
Key players in the Global Tuberculosis (TB) Testing Market, according to a report by Transparency Market Research, are Becton, Dickinson and Company, F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Hain Lifescience GmbH, Hologic Inc. QIAGEN, Abbott Laboratories, Alere Inc., Epistem plc, Cepheid, bioMérieux SA, Akonni Biosystems Inc., and Sanofi. Among them, the top players namely, Becton, Dickinson and Company, F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific, and Hain Lifescience GmbH
Tuberculosis Testing Market to Increasing Tuberculosis Awareness and Control Pro …
A new Transparency Market Research report states that the global tuberculosis testing market stood at US$1.9 bn in 2013 and is predicted to reach US$2.6 bn by 2020. It is predicted to expand at a CAGR of 4.30% from 2014 to 2020. The title of the report is “Tuberculosis Testing Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2020.” As per the report, the rising acceptance